MedTrace Logo

Impact of Direct Outreach to Expand Access to Naloxone in the Context of Standing Orders

NCT03241771 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 325

Last updated 2023-08-24

No results posted yet for this study

Summary

In the setting of naloxone standing orders, this study will assess if direct outreach with a web-based "Naloxone Navigator 1.0" to patients prescribed chronic opioid therapy (COT) changes opioid risk behaviors, increases naloxone uptake, and increases knowledge about overdose and naloxone

Conditions

Interventions

BEHAVIORAL

Naloxone Navigator 1.0

Patients on chronic opioid therapy will be outreached via email, mail and phone. Within 1 month of enrollment into the trial, intervention participants will receive a link to the web-based resource to view. This is designed to provide overdose education, increase opioid risk awareness, and encourage patients to obtain naloxone.

Sponsors & Collaborators

  • Denver Health and Hospital Authority

    collaborator OTHER

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • Kaiser Permanente

    lead OTHER

Principal Investigators

  • Ingrid Binswanger, MD · Kaiser Permanente

  • Jason Glanz, PhD · Kaiser Permanente

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-14
Primary Completion
2018-08-14
Completion
2022-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03241771 on ClinicalTrials.gov